Jasmin Bahlo

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.

Journal: The New England journal of medicine
Published: May 10, 2023

Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

Journal: European journal of haematology
Published: November 10, 2021

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients.

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients.

Journal: Haematologica
Published: March 01, 2020

High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia.

High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia.

Journal: Blood
Published: January 29, 2020

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).

Journal: Haematologica
Published: December 26, 2019

Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.

Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.

Journal: Blood
Published: December 23, 2019

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.

Journal: Blood
Published: September 23, 2019

Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.

Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.

Journal: Leukemia
Published: September 20, 2019

Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG).

Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG).

Journal: HemaSphere
Published: August 31, 2019

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial.

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial.

Journal: Leukemia
Published: June 12, 2019

Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).

Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).

Journal: American journal of hematology
Published: June 11, 2019

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.

Journal: The New England journal of medicine
Published: June 06, 2019
Showing 1-12 of 64

Last Updated: 09/26/2026